Clinical Trials
23
Active:2
Completed:13
Trial Phases
3 Phases
Phase 1:10
Phase 2:10
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (47.6%)Phase 2
10 (47.6%)Phase 3
1 (4.8%)Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)
Phase 2
Terminated
- Conditions
- Mesothelioma, Malignant
- Interventions
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Morphotek
- Target Recruit Count
- 124
- Registration Number
- NCT02357147
Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
Phase 1
Completed
- Conditions
- AdenocarcinomaColorectal CancerCarcinoma, Non-Small-Cell LungBreast CancerPancreatic Cancer
- Interventions
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Morphotek
- Target Recruit Count
- 27
- Registration Number
- NCT01761240
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Phase 1
Completed
- Conditions
- Anaplastic Large Cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNoncutaneous Extranodal LymphomaPost-transplant Lymphoproliferative DisorderRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Childhood Grade III Lymphomatoid GranulomatosisChildhood Burkitt Lymphoma
- First Posted Date
- 2012-12-12
- Last Posted Date
- 2016-01-08
- Lead Sponsor
- Morphotek
- Target Recruit Count
- 27
- Registration Number
- NCT01748721
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
🇺🇸University of California San Francisco Medical Center - Parnassus, San Francisco, California, United States
Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation
Phase 2
Completed
- Conditions
- Metastatic Soft Tissue Sarcoma
- Interventions
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- Morphotek
- Target Recruit Count
- 209
- Registration Number
- NCT01574716
- Locations
- 🇺🇸
Sarcoma Oncology Center, Santa Monica, California, United States
🇺🇸UCLA, Santa Monica, California, United States
🇺🇸Mayo Clinic Jacksonville, Jacksonville, Florida, United States
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Phase 1
Completed
- Conditions
- MesotheliomaOvarian CancerNon-small Cell Lung CancerPancreatic Cancer
- Interventions
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2016-09-30
- Lead Sponsor
- Morphotek
- Target Recruit Count
- 6
- Registration Number
- NCT01521325
- Locations
- 🇺🇸
National Cacner Institue, Bethesda, Maryland, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found